JPH0422618B2 - - Google Patents
Info
- Publication number
- JPH0422618B2 JPH0422618B2 JP62210714A JP21071487A JPH0422618B2 JP H0422618 B2 JPH0422618 B2 JP H0422618B2 JP 62210714 A JP62210714 A JP 62210714A JP 21071487 A JP21071487 A JP 21071487A JP H0422618 B2 JPH0422618 B2 JP H0422618B2
- Authority
- JP
- Japan
- Prior art keywords
- activated carbon
- adsorbent
- tio
- mgo
- composite
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 95
- 239000003463 adsorbent Substances 0.000 claims description 34
- 229910010413 TiO 2 Inorganic materials 0.000 claims description 19
- 239000002131 composite material Substances 0.000 claims description 16
- 238000011282 treatment Methods 0.000 claims description 5
- 230000008081 blood perfusion Effects 0.000 claims description 4
- 239000002245 particle Substances 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 239000011148 porous material Substances 0.000 claims description 3
- 208000017169 kidney disease Diseases 0.000 claims description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 16
- 229910052698 phosphorus Inorganic materials 0.000 description 16
- 239000011574 phosphorus Substances 0.000 description 16
- 238000000034 method Methods 0.000 description 13
- 238000001179 sorption measurement Methods 0.000 description 13
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 7
- 235000011114 ammonium hydroxide Nutrition 0.000 description 7
- 239000000395 magnesium oxide Substances 0.000 description 7
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- 229940109239 creatinine Drugs 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000010936 titanium Substances 0.000 description 6
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 5
- 238000000502 dialysis Methods 0.000 description 5
- 239000011777 magnesium Substances 0.000 description 5
- 229910052749 magnesium Inorganic materials 0.000 description 5
- 229910052719 titanium Inorganic materials 0.000 description 5
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical class [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 4
- 201000005991 hyperphosphatemia Diseases 0.000 description 4
- 239000011259 mixed solution Substances 0.000 description 4
- 239000002243 precursor Substances 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229910017604 nitric acid Inorganic materials 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 239000011295 pitch Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 229920001059 synthetic polymer Polymers 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 235000013162 Cocos nucifera Nutrition 0.000 description 2
- 244000060011 Cocos nucifera Species 0.000 description 2
- 208000001647 Renal Insufficiency Diseases 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 238000002441 X-ray diffraction Methods 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000010304 firing Methods 0.000 description 2
- 238000005470 impregnation Methods 0.000 description 2
- 201000006370 kidney failure Diseases 0.000 description 2
- YIXJRHPUWRPCBB-UHFFFAOYSA-N magnesium nitrate Chemical compound [Mg+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O YIXJRHPUWRPCBB-UHFFFAOYSA-N 0.000 description 2
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- VXUYXOFXAQZZMF-UHFFFAOYSA-N titanium(IV) isopropoxide Chemical compound CC(C)O[Ti](OC(C)C)(OC(C)C)OC(C)C VXUYXOFXAQZZMF-UHFFFAOYSA-N 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- OEPOKWHJYJXUGD-UHFFFAOYSA-N 2-(3-phenylmethoxyphenyl)-1,3-thiazole-4-carbaldehyde Chemical compound O=CC1=CSC(C=2C=C(OCC=3C=CC=CC=3)C=CC=2)=N1 OEPOKWHJYJXUGD-UHFFFAOYSA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 206010062237 Renal impairment Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 238000003763 carbonization Methods 0.000 description 1
- 229920006026 co-polymeric resin Polymers 0.000 description 1
- 238000000975 co-precipitation Methods 0.000 description 1
- 239000011300 coal pitch Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 239000002612 dispersion medium Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000013022 formulation composition Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000005977 kidney dysfunction Effects 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000005976 liver dysfunction Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000034217 membrane fusion Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000002905 metal composite material Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000003791 organic solvent mixture Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000011301 petroleum pitch Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000005011 phenolic resin Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000000634 powder X-ray diffraction Methods 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000008085 renal dysfunction Effects 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000006190 sub-lingual tablet Substances 0.000 description 1
- 229940098466 sublingual tablet Drugs 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 238000005979 thermal decomposition reaction Methods 0.000 description 1
- 229920005992 thermoplastic resin Polymers 0.000 description 1
- 229920001187 thermosetting polymer Polymers 0.000 description 1
- -1 titanium alkoxides Chemical class 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Landscapes
- External Artificial Organs (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62210714A JPS6456141A (en) | 1987-08-25 | 1987-08-25 | Novel adsorbent |
| EP88307827A EP0311244B1 (en) | 1987-08-25 | 1988-08-24 | Complex of magnesium oxide and titanium dioxide as a phosphate adsorbent |
| DE8888307827T DE3881141T2 (de) | 1987-08-25 | 1988-08-24 | Zusammensetzung aus magnesiumoxyd und titandioxyd als phosphatsorbentmittel. |
| US07/235,415 US4988569A (en) | 1987-08-25 | 1988-08-24 | Complex phosphate adsorbent of MgO-TiO2 |
| ES88307827T ES2054816T3 (es) | 1987-08-25 | 1988-08-24 | Complejo de oxido de magnesio y dioxido de titanio como un adsorbente de fosfato. |
| CA000575490A CA1324601C (en) | 1987-08-25 | 1988-08-24 | Complex phosphate adsorbent |
| KR1019880010842A KR910004018B1 (ko) | 1987-08-25 | 1988-08-25 | 복합 인산염 흡착제 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62210714A JPS6456141A (en) | 1987-08-25 | 1987-08-25 | Novel adsorbent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6456141A JPS6456141A (en) | 1989-03-03 |
| JPH0422618B2 true JPH0422618B2 (ru) | 1992-04-20 |
Family
ID=16593885
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP62210714A Granted JPS6456141A (en) | 1987-08-25 | 1987-08-25 | Novel adsorbent |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6456141A (ru) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4910261A (en) * | 1988-06-17 | 1990-03-20 | Edison Polymer Innovation Corp. (Epic) | Thermoplastic elastomers having isobutylene block and cyclized diene blocks |
| JP2746292B2 (ja) * | 1990-08-31 | 1998-05-06 | インターナショナル・ビジネス・マシーンズ・コーポレイション | スパッタリング装置 |
| US7651974B2 (en) | 2002-11-01 | 2010-01-26 | Kureha Chemical Industry Co., Ltd. | Adsorbent for oral administration |
| TWI370013B (en) | 2004-04-02 | 2012-08-11 | Kureha Corp | Adsorbent for oral administration, and agent for treating or preventing renal or liver disease |
| TWI370012B (en) | 2004-04-02 | 2012-08-11 | Kureha Corp | Adsorbent for oral administration, and agent for treating or preventing renal or liver disease |
| JP5732676B2 (ja) * | 2010-03-31 | 2015-06-10 | 富田製薬株式会社 | 透析組成物、血液透析システムおよび血液透析器 |
| JPWO2017082423A1 (ja) * | 2015-11-11 | 2018-08-30 | 旭化成メディカル株式会社 | 血液処理用リン吸着剤、血液処理システム及び血液処理方法 |
| KR102399758B1 (ko) * | 2017-05-17 | 2022-05-20 | 아사히 가세이 메디컬 가부시키가이샤 | 혈액 처리용 인 흡착제, 혈액 처리 시스템 및 혈액 처리 방법 |
-
1987
- 1987-08-25 JP JP62210714A patent/JPS6456141A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6456141A (en) | 1989-03-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4822765A (en) | Process for treating activated carbon with aqueous ammonia | |
| TWI319985B (en) | Adsorbent for oral administration, agent for treating or preventing renal disease, and agent for treating or preventing liver disease | |
| KR910004018B1 (ko) | 복합 인산염 흡착제 | |
| EP0029715B1 (en) | Porous spherical carbonaceous product and production thereof | |
| CA1139673A (en) | Spherical particles of activated carbon suitable for use as an antidotal pharmaceutical composition | |
| JP3522708B2 (ja) | 経口投与用吸着剤 | |
| CA1112172A (en) | Antidote consisting of particles of activated carbon | |
| US8920796B2 (en) | Adsorbent for oral administration, and agent for treating or preventing renal or liver disease | |
| KR101856048B1 (ko) | 의약용 흡착제 및 그 제조방법 | |
| JP3518878B2 (ja) | 抗ネフローゼ症候群剤 | |
| KR100680449B1 (ko) | 경구투여용 흡착제 | |
| CA2608447A1 (en) | Oxidative stress inhibitor | |
| JPH0422618B2 (ru) | ||
| CN1132075A (zh) | 药物的肾毒性减轻剂 | |
| JPH05155776A (ja) | 高リン血症治療剤 | |
| WO2014129618A1 (ja) | 経口投与用吸着剤並びに腎疾患治療剤及び肝疾患治療剤 | |
| JP6431475B2 (ja) | 経口投与用吸着剤並びに腎疾患治療剤及び肝疾患治療剤 | |
| JP5985027B2 (ja) | 経口投与用医薬用吸着剤の製造方法 | |
| JPS62223125A (ja) | 経口解毒剤 | |
| JPH0455737B2 (ru) | ||
| Okazaki et al. | Complex phosphate adsorbent of MgO-TiO 2 | |
| KR840001449B1 (ko) | 다공성 구상 탄소질 생성물의 제조방법 | |
| JP2005162683A (ja) | 高尿酸血症の治療又は予防剤 | |
| JP2006096769A (ja) | 経口投与用吸着剤、並びに腎疾患治療又は予防剤、及び肝疾患治療又は予防剤 |